M

Researcher Profile

Mark Baxter

1

Publications

74

Citations

10

Co-Authors

1

Active Years

Publications

Open Access Journal Article The Lancet Oncology Mar 01, 2023

Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial

Janet E Brown · Kara-Louise Royle · Walter Gregory · Christy Ralph +94 more

10.1016/s1470-2045(22)00793-8 74 citations

Publication Timeline

2023

1

Frequent Co-Authors

Natalie Charnley

Caroline Manetta

Alberto J.M. Martin

Geoffrey Sparrow

Gopalakrishnan Srinivasan

Kara-Louise Royle